Truscreen Group Ltd (TRU) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Truscreen Group Ltd (TRU) has a cash flow conversion efficiency ratio of -0.502x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.68 Million ≈ $-1.19 Million USD) by net assets (AU$3.35 Million ≈ $2.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Truscreen Group Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Truscreen Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Truscreen Group Ltd (TRU) total liabilities for a breakdown of total debt and financial obligations.
Truscreen Group Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Truscreen Group Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Spago Nanomedical AB
ST:SPAGO
|
-0.201x |
|
Ace Digital AS
OL:ACED
|
N/A |
|
National Plastic Co Ltd Preferred
KO:004255
|
0.027x |
|
GENINCODE PLC LS -01
F:9PL
|
N/A |
|
Sky Quarry Inc
NASDAQ:SKYQ
|
-0.229x |
|
Ho Hup Construction Company
KLSE:5169
|
0.004x |
|
Noble Mineral Exploration Inc
V:NOB
|
-0.094x |
|
Gasporox AB (publ)
ST:GPX
|
-0.009x |
Annual Cash Flow Conversion Efficiency for Truscreen Group Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of Truscreen Group Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Truscreen Group Ltd (TRU) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | AU$1.01 Million ≈ $713.49K |
AU$-2.29 Million ≈ $-1.62 Million |
-2.270x | -260.88% |
| 2023-12-31 | AU$3.23 Million ≈ $2.29 Million |
AU$-2.03 Million ≈ $-1.44 Million |
-0.629x | +27.11% |
| 2022-12-31 | AU$2.54 Million ≈ $1.80 Million |
AU$-2.19 Million ≈ $-1.55 Million |
-0.863x | -15.73% |
| 2021-12-31 | AU$3.40 Million ≈ $2.40 Million |
AU$-2.53 Million ≈ $-1.79 Million |
-0.746x | -285.20% |
| 2020-12-31 | AU$11.31 Million ≈ $8.00 Million |
AU$-2.19 Million ≈ $-1.55 Million |
-0.194x | +14.24% |
| 2019-12-31 | AU$7.24 Million ≈ $5.12 Million |
AU$-1.63 Million ≈ $-1.16 Million |
-0.226x | +4.59% |
| 2018-12-31 | AU$11.32 Million ≈ $8.01 Million |
AU$-2.68 Million ≈ $-1.90 Million |
-0.237x | +26.31% |
| 2017-12-31 | AU$11.62 Million ≈ $8.22 Million |
AU$-3.73 Million ≈ $-2.64 Million |
-0.321x | -78.55% |
| 2016-12-31 | AU$14.32 Million ≈ $10.14 Million |
AU$-2.58 Million ≈ $-1.82 Million |
-0.180x | -284.17% |
| 2015-12-31 | AU$14.15 Million ≈ $10.01 Million |
AU$-662.10K ≈ $-468.48K |
-0.047x | +69.78% |
| 2014-12-31 | AU$9.86 Million ≈ $6.97 Million |
AU$-1.53 Million ≈ $-1.08 Million |
-0.155x | -321.40% |
| 2013-12-31 | AU$10.40 Million ≈ $7.36 Million |
AU$-382.34K ≈ $-270.53K |
-0.037x | -- |
About Truscreen Group Ltd
TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The comp… Read more